About Xantis Pharma
Xantis Pharma is a Healthcare company based in Zug (Switzerland) founded in 2015. Distributor of generic prescription and over-the-counter products. Xantis Pharma has completed 2 acquisitions, including ALSI Pharma and IPS Middle East. Its chief executive, as recorded, is Tim Oreskovic. Xantis Pharma offers products and services including Pharmaceutical Treatments and Treatment Solutions. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is Xantis Pharma AG. Its competitors include DCS Pharma, RUWAG and Globomedica.
Company details
Xantis Pharma distributor of generic prescription and over-the-counter products through providing healthcare solutions, pharmaceutical distributors, and diversified. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Zug, Switzerland
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website xantispharma.com
- Social LinkedIn
- Legal Name Xantis Pharma Ag
- Investments & AcquisitionsALSI Pharma
& 1 more
Products & Services of Xantis Pharma
Xantis Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Treatments and Treatment Solutions.
Offers safe and affordable medical treatments for consumers.
Provides fairly priced options for health and wellness needs.
People of Xantis Pharma
2 people are tracked at Xantis Pharma (2 in leadership).
| Name | Role | Group |
|---|---|---|
Tim Oreskovic | CEO | Leadership |
Lars Ramneborn | CEO | Leadership |
Complete people profiles for Xantis Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Xantis Pharma
Xantis Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include ALSI Pharma and IPS Middle East.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Generic finished formulations are manufactured for various therapeutic categories. | ips-me.com | Beirut, Lebanon | 2012 | Dec 2018 | •••• | |
North Sea natural gas exploration and production are emphasized. | alsipharma.com | Moscow, Russia | 2000 | Sep 2017 | •••• |
Complete acquisition details for Xantis Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Xantis Pharma
3 dated milestones of Xantis Pharma across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Xantis Pharma is founded.
- Acquisition Acquires ALSI Pharma.
- Acquisition Acquires IPS Middle East.
Competitors of Xantis Pharma
Xantis Pharma has 3 listed competitors in our database. They include DCS Pharma, RUWAG and Globomedica.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dcspharma.com | 2016 | Basel, Switzerland | Pharmaceutical products are distributed by DCS Pharma in Switzerland. | |||
| ruwag.ch | 1987 | Bettlach, Switzerland | Distributor of drugs | |||
| globomedica.ch | 2009 | Egg, Switzerland | Diversified pharmaceutical drugs are distributed by Globomedica in Switzerland. |
Detailed competitors of Xantis Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Xantis Pharma
The website of Xantis Pharma (xantispharma.com) receives about 2.1K visits a month and ranks #8,809,981 among all websites worldwide, #7,496 in Biotechnology and Pharmaceuticals.
- Monthly visits2.1K
▲ 23.7% vs previous month
- Global rank#8,809,981
among all websites
- Category rank#7,496
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit1.9
- Average visit53 sec
- DevicesDesktop 43% · Mobile 57%
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Xantis Pharma
Complete news archive for Xantis Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Xantis Pharma
Xantis Pharma was founded in 2015.
Xantis Pharma is headquartered in Zug, Switzerland. It is registered at Zug, Zug, Switzerland.
Tim Oreskovic is the CEO of Xantis Pharma, as recorded in our data.
Xantis Pharma distributor of generic prescription and over-the-counter products through providing healthcare solutions, pharmaceutical distributors, and diversified. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Xantis Pharma's top competitors include DCS Pharma, RUWAG and Globomedica.
Xantis Pharma offers Pharmaceutical Treatments and Treatment Solutions.
Xantis Pharma has made 2 acquisitions, including ALSI Pharma, and IPS Middle East.
Xantis Pharma operates through Xantis Pharma Ag.